Still extremely interested in $HYPR
First FDA-cleared AI-powered portable MRI system with a massively expanding global TAM (200+ IP’s). Hospitals, surgeries, battlefield etc.
Growing adoption and approvals worldwide (UK, India etc.). Transitioning from R&D to commercialisation (10 units sold in Q126).
Partners with and grant recipients of the Bill & Melinda Gates Foundation.
Collaboration with $NVDA to enhance their Optive AI solution.
Insiders own ~31% of the float including the founder with 17m shares (16.6%). Hardly any sales, only to cover tax.
20% tute ownership. Vanguard own 4.34%. $GOOG have owned 900k shares since 2022 and haven’t sold.
Gross margins expanding from 41.3% to 50.7%. Cash burn and operating loss decreasing 13% and 21% YoY respectively. R&D expenses decreased 24% YoY. Asset/liability ratio is OK.
$40.8m cash and equivalents with runway into 2028, easing dilution.
Good R/R for a small position for me.
NFA.